Jia Zeng – Trademark Portfolio
Entity Type: 01
Jia Zeng owns a portfolio of 16 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as ZXYK, ZYRX, OSFINE, XIBADA, and LIKSONG. Of these, 11 are registered and 4 are pending. The portfolio spans 8 Nice Classification classes, led by Class 15 (Musical Instruments) and Class 25 (Clothing). Headquartered in Xiamen, Fujian.
Rm 203
No.20 Guanri West Erli, Huli Dist
Xiamen, Fujian 361000 , CN
Showing of trademarks Trademarks
Trademark Classifications
Jia Zeng's trademark portfolio spans 8 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Meat, fish, poultry and game; meat extracts; preserved, frozen, dried and cooked fruits
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Apparatus for lighting, heating, steam generating, cooking, refrigerating, drying
Paper and cardboard; printed matter; bookbinding material; photographs; stationery
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Jia Zeng have?
Jia Zeng has 16 U.S. trademarks filed with the USPTO. Of these, 11 registered, 4 pending, 1 cancelled.
What trademark classes does Jia Zeng file in?
Jia Zeng files trademarks across 8 Nice Classification classes. The most active classes are Class 15 (Musical Instruments), Class 25 (Clothing), Class 24 (Fabrics), Class 29 (Meats & Processed Foods), Class 18 (Leather Goods). Class 15 covers musical instruments.
What are Jia Zeng's most well-known trademarks?
Jia Zeng's registered trademark portfolio includes well-known marks such as ZXYK, ZYRX, OSFINE, XIBADA, and LIKSONG. These are among 11 currently registered trademarks in the portfolio.
What is Jia Zeng's trademark registration success rate?
Jia Zeng has a 92% trademark registration rate, with 11 out of 12 resolved applications resulting in successful registration. Currently, 4 applications are pending review.